These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 31792138)
1. Detection Assay for Replication-Competent Adenovirus by Concentration Passage and Real-Time Quantitative Polymerase Chain Reaction (qPCR). Lock M; Alvira M; Wilson J; Sena-Esteves M; Gao G Cold Spring Harb Protoc; 2019 Dec; 2019(12):. PubMed ID: 31792138 [TBL] [Abstract][Full Text] [Related]
2. A replication-competent adenovirus assay for E1-deleted Ad35 vectors produced in PER.C6 cells. Marzio G; Kerkvliet E; Bogaards JA; Koelewijn S; De Groot A; Gijsbers L; Weverling GJ; Vogels R; Havenga M; Custers J; Pau MG; Guichoux JY; Lewis J; Goudsmit J Vaccine; 2007 Mar; 25(12):2228-37. PubMed ID: 17250936 [TBL] [Abstract][Full Text] [Related]
3. Establishment of a novel cell line for producing replication-competent adenovirus-free adenoviruses. Han EY; Kim YJ BMC Biotechnol; 2024 Sep; 24(1):67. PubMed ID: 39334326 [TBL] [Abstract][Full Text] [Related]
4. A single short stretch of homology between adenoviral vector and packaging cell line can give rise to cytopathic effect-inducing, helper-dependent E1-positive particles. Murakami P; Pungor E; Files J; Do L; van Rijnsoever R; Vogels R; Bout A; McCaman M Hum Gene Ther; 2002 May; 13(8):909-20. PubMed ID: 12031124 [TBL] [Abstract][Full Text] [Related]
5. A qPCR-Based Method for Quantification of Replication Competent Adenovirus (RCA) in Conditionally Replicating Oncolytic Adenoviruses. Yngve E; Gao M; Yu D Methods Mol Biol; 2022; 2521():249-258. PubMed ID: 35733002 [TBL] [Abstract][Full Text] [Related]
6. A rapid and sensitive assay for detection of replication-competent adenoviruses by a combination of microcarrier cell culture and quantitative PCR. Schalk JA; de Vries CG; Orzechowski TJ; Rots MG J Virol Methods; 2007 Nov; 145(2):89-95. PubMed ID: 17588680 [TBL] [Abstract][Full Text] [Related]
7. Detection of replication-competent adenoviruses spiked into recombinant adenovirus vector products by infectivity PCR. Ishii-Watabe A; Uchida E; Iwata A; Nagata R; Satoh K; Fan K; Murata M; Mizuguchi H; Kawasaki N; Kawanishi T; Yamaguchi T; Hayakawa T Mol Ther; 2003 Dec; 8(6):1009-16. PubMed ID: 14664804 [TBL] [Abstract][Full Text] [Related]
8. Detection of replication competent adenovirus upon serial passaging of recombinant adenovirus expressing FMDV capsid proteins. Kumar R; Basagoudanavar SH; Sreenivasa BP Biologicals; 2015 May; 43(3):209-12. PubMed ID: 25748638 [TBL] [Abstract][Full Text] [Related]
9. Trans-complementation of vector replication versus Coxsackie-adenovirus-receptor overexpression to improve transgene expression in poorly permissive cancer cells. Fechner H; Wang X; Wang H; Jansen A; Pauschinger M; Scherübl H; Bergelson JM; Schultheiss HP; Poller W Gene Ther; 2000 Nov; 7(22):1954-68. PubMed ID: 11127584 [TBL] [Abstract][Full Text] [Related]
10. Replication-competent adenovirus formation in 293 cells: the recombination-based rate is influenced by structure and location of the transgene cassette and not increased by overproduction of HsRad51, Rad51-interacting, or E2F family proteins. Duigou GJ; Young CS J Virol; 2005 May; 79(9):5437-44. PubMed ID: 15827158 [TBL] [Abstract][Full Text] [Related]
12. Adenoviral Gene Therapy Vectors in Clinical Use-Basic Aspects with a Special Reference to Replication-Competent Adenovirus Formation and Its Impact on Clinical Safety. Leikas AJ; Ylä-Herttuala S; Hartikainen JEK Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003709 [TBL] [Abstract][Full Text] [Related]
13. [The genetic stability of non-replicating recombinant adenoviruses on 293 cells during continuous passage]. Wang M; Shu Y; Tian R; Qu JG; Wang JW; Hung T Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Feb; 22(1):42-4. PubMed ID: 18414698 [TBL] [Abstract][Full Text] [Related]
14. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase. Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394 [TBL] [Abstract][Full Text] [Related]
15. Development of a recombinant adenovirus vector production system free of replication-competent adenovirus by utilizing a packaging size limit of the viral genome. Suzuki T; Sasaki T; Yano K; Sakurai F; Kawabata K; Kondoh M; Hayakawa T; Yagi K; Mizuguchi H Virus Res; 2011 Jun; 158(1-2):154-60. PubMed ID: 21470569 [TBL] [Abstract][Full Text] [Related]
16. Degenerated pIX-IVa2 adenoviral vector sequences lowers reacquisition of the E1 genes during virus amplification in 293 cells. Robert JJ; Gauffeny I; Maccario J; Jullien C; Benoit P; Vigne E; Crouzet J; Perricaudet M; Yeh P Gene Ther; 2001 Nov; 8(22):1713-20. PubMed ID: 11892839 [TBL] [Abstract][Full Text] [Related]
17. A qPCR-Based Method for Quantification of RCA Contaminants in Oncolytic Adenovirus Products. Gao M; Yngve E; Yu D; Jin C Front Mol Biosci; 2022; 9():883249. PubMed ID: 35677885 [TBL] [Abstract][Full Text] [Related]
18. Design, validation and evaluation of a SYBR green-based quantitative PCR array for comprehensive analysis of adenovirus type 5 transcriptional patterns. Nebeluk N; Foster TP J Virol Methods; 2020 Jul; 281():113880. PubMed ID: 32413477 [TBL] [Abstract][Full Text] [Related]
19. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Fallaux FJ; Bout A; van der Velde I; van den Wollenberg DJ; Hehir KM; Keegan J; Auger C; Cramer SJ; van Ormondt H; van der Eb AJ; Valerio D; Hoeben RC Hum Gene Ther; 1998 Sep; 9(13):1909-17. PubMed ID: 9741429 [TBL] [Abstract][Full Text] [Related]
20. A simple method for the simultaneous detection of E1A and E1B in adenovirus stocks. Suzuki E; Murata T; Watanabe S; Kujime Y; Hirose M; Pan J; Yamazaki T; Ugai H; Yokoyama KK Oncol Rep; 2004 Jan; 11(1):173-8. PubMed ID: 14654922 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]